Large-scale testing (Phase 3)Study completedNCT00495287
What this trial is testing
A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)
Who this might be right for
Acute Myelogenous Leukemia
Northern Italy Leukemia Group 573